Braskem Misses Its Own Restructuring Deadline — Is This Latin America's Largest Petrochemical Company Running Out of Time?
Shares of Braskem cratered 18.4% to BRL 3.02 after the company confirmed it failed to reach a restructuring agreement by its self-imposed October 30 deadline, deepening a selloff that has erased 62% of the stock's value this year. For investors, the missed milestone raises a stark question: can Brazil's biggest petrochemicals producer avoid a full judicial bankruptcy?
• A $10.9 Billion Debt Load With No Deal in Sight. Braskem's board approved an out-of-court restructuring in August to negotiate $10.9 billion in unsecured obligations while keeping day-to-day operations running.
The company has now clarified that no final agreement has been reached, with negotiations continuing past the extended October 30 deadline.
Corporate leverage ended 2025 at a staggering 14.7x net debt to EBITDA — meaning the company would need roughly 15 years of current earnings just to pay down what it owes. Every week without a deal increases the risk that creditors force the process into formal court proceedings.
• Creditors and Shareholders Are Billions Apart. Creditors proposed a $1.85 billion backstop for a $2.25 billion equity offering alongside $1.85 billion in debt-to-equity conversion, while Braskem countered with a smaller $1.2 billion backstop and roughly $2.8 billion in conversions.
Creditors are also demanding broader collateral across Braskem's assets in Brazil, the U.S. and Europe, plus higher interest rates on restructured debt. The gap matters because a debt-to-equity swap — where lenders trade their IOUs for ownership stakes — would massively dilute current shareholders.
• An Involuntary Bankruptcy Filing Adds Pressure. Three creditors filed an involuntary Chapter 11 petition on October 21 against Braskem's U.S. finance unit.
The next critical dates are October 30 for main terms and November 22 for the creditor support a court would need. If out-of-court talks collapse entirely, the company could be dragged into a judicial reorganization — a messier, longer process that historically destroys more equity value.
• The Market Is Pricing In Severe Dilution or Worse. Braskem's market capitalization has shriveled to just BRL 2.49 billion — a fraction of its debt pile. Creditors want debt converted into shares at BRL 2 each , which at the proposed conversion scale would hand lenders a controlling stake. For existing shareholders, the math is punishing: even a successful restructuring likely leaves them holding a much smaller slice of the company.